Clinical Trials

Gold Divider 4Col
Clinical Trials

Participating in Mount Sinai’s clinical trials allows you to take advantage of innovative treatments as we work together to advance the future of medicine.

View All Service Areas

Discover how The Mount Sinai Medical Center can offer you the most advanced and compassionate inpatient and outpatient care.

Institutes, Centers, Programs and Laboratories

The Mount Sinai Medical Center is home to an extensive array of top-notch research centers and laboratories, where scientists and researchers work to translate the rapid advances in basic science into the innovative patient care for which we are known.

Coping with Inflammatory Bowel Disease Surveillance and Risk

Coping with Inflammatory Bowel Disease Surveillance and Risk

The purpose of this study is to gather information about how people with inflammatory bowel disease (IBD) cope with surveillance colonoscopy and their high risk for colorectal cancer. Participants in this research will complete an initial telephone interview that will take about 45 minutes and a mailed questionnaire that will take about the same amount of time. The initial interview and questionnaire will include questions about their background, their personal characteristics, their relationship with their spouse or partner, their history of IBD, and their thoughts and feelings about IBD, your risk for colorectal cancer, and cancer risk reduction options such as surveillance and surgery. After they complete the initial interview and questionnaire, they will be asked to complete a very brief questionnaire each night for 4 weeks (called a daily diary questionnaire), beginning about 2 weeks before their scheduled follow-up surveillance colonoscopy and ending about 2 weeks after it. Each daily diary questionnaire takes 5 minutes or less to complete and asks about events that occurred that day. The study ends with a follow-up telephone interview that will take about 45 minutes and that will include questions similar to those asked in the initial interview and questionnaire. Participants' medical records will be reviewed to assess information about their IBD (for instance, whether they have ulcerative colitis or Crohns disease, and the extent of their disease) and the results of their surveillance colonoscopies. In addition, if they are willing, their spouse or partner will be invited to participate in this study by completing their own initial interview, daily diary questionnaires, and follow-up interview. Patients may participate whether or not their spouse or partner participates.

  • Principal Investigator

    Christine M. Rini
  • Compensation

    Y
  • Inclusion

    Participants must be 1) IBD patients who are 2) scheduled for a surveillance colonoscopy to follow up on a prior colonoscopy that detected dysplasia or a similar condition. They must be 3) English speaking, 4) adults (18 years or older), and 5) married or in a committed romantic relationship. Each patient's spouse or partner will also be invited to participate. Spouses or partners must be English speaking adults (18 years or older).
  • Exclusion

    IBD patients and partners will be excluded from participation if they show evidence of 1) cognitive impairment that prevents them from understanding and providing informed consent or that prevents their full participation in study assessments or 2) if they do not speak English.
  • Sponsoring Organization

    Mount Sinai Medical Center
  • Department Name

    MSSM Cancer Center
  • GCO Number

    03-0141
  • IRB Start/End Date

    September 1, 2009 to August 31, 2010

Coming to Mount Sinai?

Directions

Arrive at the Medical Center by car, public transportation and from all area airports.

Find A Faculty Member

Events

Search for Events

Mount Sinai has scheduled events for faculty, physicians, students, staff, and the community. View events by day, week, and month.

(800) MD-SINAI (800) 637-4624

Visit Mount Sinai Queens